首页 > 组织芯片 > > DLV8015
tissue microarray-DLV8015
  • 点数:
    80
    例数:
    80
    点样直径(mm):
    2
    厚度(µm):
    5
    行数:
    8
    列数:
    10
    组织阵列类型:
    FFPE
    种属:
    Human
DLV8015
加入收藏

描述: 肝脏疾病谱组织组合芯片,附病理分级、TNM、临床分期和免疫组化()结果,80例/80点

详情: 肝脏疾病谱组织组合微阵列,包含肝细胞肝癌20例,胆管细胞癌20例,5例转移癌,12例肝硬化,1例肝纤维化,2例增生,10例肝炎,5例非酒精性脂肪肝,肝组织5例,一例一点

应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Liver
  • Cirrhosis(*)
  • Fibrosis(*)
  • Inflammation(*)
  • Fatty liver(*)
  • Metastasis(*)
  • Malignant(I)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Normal(*)
  • Hyperplasia(*)
  • _ma
组织芯片
DLV8015
1
2
3
4
5
6
7
8
9
10
A
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
B
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
C
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
D
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
E
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
F
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
G
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
H
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
_ma
DLV8015
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
POS No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 65 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant *
A2
2 24 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant 5*4*2.5
A3
3 55 M Liver Hepatocellular carcinoma 1--2 T2N0M0 II Malignant *
A4
4 53 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.0*5.0*4.0
A5
5 36 F Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
A6
6 36 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 8*5*7
A7
7 48 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 6*5*4
A8
8 51 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 3.5
A9
9 63 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 9*8*5
A10
10 36 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 3*2*2
B1
11 32 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5*4*3
B2
12 77 M Liver Hepatocellular carcinoma 2 T3aN0M0 IIIA Malignant 6.0*5.0*5
B3
13 50 M Liver Hepatocellular carcinoma 2--3 T2N0M0 II Malignant *
B4
14 48 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 11*7*3
B5
15 38 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 15.5*12*4
B6
16 43 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant 4*3*2
B7
17 47 F Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 12*5*5
B8
18 51 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 9x6x5.5
B9
19 65 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 7*6
B10
20 57 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 4.5*3.5
C1
21 50 F Liver Cholangiocellular carcinoma 1--2 T3N1M0 IIIB Malignant 5
C2
22 60 F Liver Cholangiocellular carcinoma 2 T2aN0M0 II Malignant 3*2.5*2.5
C3
23 39 F Liver Cholangiocellular carcinoma 2 T3N1M0 IIIB Malignant 9*9
C4
24 58 F Liver Cholangiocellular carcinoma with necrosis 2 T2N0M0 II Malignant *
C5
25 52 M Liver Cholangiocellular carcinoma 2 T1N0M0 I Malignant 7*5
C6
26 51 F Liver Cholangiocellular carcinoma 2 T3N1M0 IIIB Malignant 7
C7
27 67 F Liver Cholangiocellular carcinoma (sparse) 2 T3N1M0 IIIB Malignant 4
C8
28 52 F Liver Cholangiocellular carcinoma 2 T3N1M0 IIIB Malignant 6.5
C9
29 55 M Liver Cholangiocellular carcinoma 2 T3N0M0 IIIA Malignant 5*4
C10
30 40 F Liver Cholangiocellular carcinoma 2 T3N0M0 IIIA Malignant 10*8*6
D1
31 62 M Liver Cholangiocellular carcinoma 2 T2N0M0 II Malignant *
D2
32 54 M Liver Cholangiocellular carcinoma with necrosis 2 T3N1M0 IIIB Malignant 9
D3
33 60 F Liver Cholangiocellular carcinoma with necrosis 2--3 T3N0M0 IIIA Malignant 7
D4
34 53 M Liver Cholangiocellular carcinoma 2--3 T3N0M0 IIIA Malignant 6
D5
35 49 M Liver Cholangiocellular carcinoma with necrosis 2--3 T4N0M0 IIIB Malignant 3*2.5
D6
36 57 F Liver Cholangiocellular carcinoma 2--3 T2N1M0 IIIB Malignant *
D7
37 57 M Liver Cholangiocellular carcinoma 3 T3N0M0 IIIA Malignant 8*9
D8
38 46 M Liver Cholangiocellular carcinoma 3 T2aN0M0 II Malignant 4*3*2
D9
39 64 M Liver Cholangiocellular carcinoma 3 T3N1M0 IIIB Malignant 9
D10
40 51 M Liver Cholangiocellular carcinoma 3 T3N1M0 IIIB Malignant *
E1
41 49 M Liver Metastatic adenocarcinoma from colon 2 * * Metastasis 12*7*2
E2
42 60 F Liver Metastatic adenocarcinoma from colon 2 * * Metastasis 3
E3
43 38 M Liver Metastatic adenocarcinoma from colon with necrosis (sparse) 2 * * Metastasis 5*4*3
E4
44 60 M Liver Metastatic adenocarcinoma from pancreas 2 * * Metastasis 11*5*5
E5
45 74 M Liver Metastatic adenocarcinoma from gallbladder 3 * * Metastasis 6*5.5
E6
46 40 M Liver Cirrhosis * * * Cirrhosis *
E7
47 59 M Liver Cirrhosis * * * Cirrhosis *
E8
48 57 F Liver Cirrhosis * * * Cirrhosis *
E9
49 58 M Liver Cirrhosis * * * Cirrhosis *
E10
50 52 F Liver Cirrhosis * * * Cirrhosis *
F1
51 53 M Liver Cirrhosis * * * Cirrhosis *
F2
52 54 M Liver Cirrhosis * * * Cirrhosis *
F3
53 45 M Liver Cirrhosis * * * Cirrhosis *
F4
54 58 M Liver Cirrhosis * * * Cirrhosis *
F5
55 72 F Liver Cirrhosis * * * Cirrhosis *
F6
56 45 M Liver Cirrhosis * * * Cirrhosis *
F7
57 48 M Liver Cirrhosis * * * Cirrhosis *
F8
58 45 M Liver Liver fibrosis * * * Fibrosis *
F9
59 37 M Liver Atypical hyperplasia * * * Hyperplasia *
F10
60 50 M Liver Hyperplasia * * * Hyperplasia *
G1
61 68 F Liver Hepatitis * * * Inflammation *
G2
62 75 F Liver Hepatitis * * * Inflammation *
G3
63 42 M Liver Hepatitis * * * Inflammation *
G4
64 52 F Liver Hepatitis * * * Inflammation *
G5
65 62 F Liver Hepatitis * * * Inflammation *
G6
66 41 M Liver Hepatitis * * * Inflammation *
G7
67 53 M Liver Hepatitis * * * Inflammation *
G8
68 52 F Liver Hepatitis * * * Inflammation *
G9
69 65 F Liver Hepatitis * * * Inflammation *
G10
70 60 M Liver Hepatitis * * * Inflammation *
H1
71 37 M Liver Non-alcoholic fatty liver * * * Fatty liver *
H2
72 40 M Liver Non-alcoholic fatty liver * * * Fatty liver *
H3
73 66 F Liver Non-alcoholic fatty liver * * * Fatty liver *
H4
74 36 F Liver Non-alcoholic fatty liver * * * Fatty liver *
H5
75 48 F Liver Non-alcoholic fatty liver * * * Fatty liver *
H6
76 75 M Liver Liver tissue * * * Normal *
H7
77 68 M Liver Liver tissue * * * Normal *
H8
78 25 M Liver Liver tissue * * * Normal *
H9
79 38 F Liver Liver tissue * * * Normal *
H10
80 55 M Liver Liver tissue * * * Normal *
_marker_
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们
0.150849s